These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 34751429)

  • 1. A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination.
    Kherlopian A; Zhao C; Ge L; Forward E; Fischer G
    Australas J Dermatol; 2022 Feb; 63(1):e93-e95. PubMed ID: 34751429
    [No Abstract]   [Full Text] [Related]  

  • 2. Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine.
    Aimo C; Mariotti EB; Corrà A; Cipollini E; Le Rose O; Serravalle C; Pimpinelli N; Caproni M
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e417-e419. PubMed ID: 35133674
    [No Abstract]   [Full Text] [Related]  

  • 3. An extremely rare mucocutaneous adverse reaction following COVID-19 vaccination: Toxic epidermal necrolysis.
    Mardani M; Mardani S; Asadi Kani Z; Hakamifard A
    Dermatol Ther; 2022 May; 35(5):e15416. PubMed ID: 35238119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome after ChAdOx1 nCoV-19 vaccine.
    da Cruz Gouveia PA; Cavalcanti LNF; Alves LCF; Almeida DM; Barretto LWA
    Indian J Dermatol Venereol Leprol; 2022; 88(5):702. PubMed ID: 35986626
    [No Abstract]   [Full Text] [Related]  

  • 5. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap After the Third Dose of BNT162b2 mRNA COVID-19 Vaccination and Literature Review.
    Jue MS; Joh HC; Kim SH; Ko JY
    Dermatitis; 2023; 34(2):158-159. PubMed ID: 36716204
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of Steven-Johnson syndrome after COVID-19 vaccination.
    Mansouri P; Farshi S
    J Cosmet Dermatol; 2022 Apr; 21(4):1358-1360. PubMed ID: 35020263
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing.
    Siripipattanamongkol N; Rattanasak S; Taiyaitieng C; Inthajak Y; Kuawatcharawong N; Sukasem C; Tempark T
    Pediatr Dermatol; 2022 Jul; 39(4):601-605. PubMed ID: 36000937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal necrolysis after COVID-19 vaccination: An exploratory analysis using World Health Organization VigiBase.
    Ahouach B; Diaz E; Bertin B; Ben Said B; Combret S; Grandvuillemin A; Petitpain N; Rabier MB; Thomas L; Trenque T; Ingen-Housz-Oro S; Lebrun-Vignes B
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):e456-e459. PubMed ID: 36606525
    [No Abstract]   [Full Text] [Related]  

  • 9. Geographical distribution of TTS cases following AZD1222 (ChAdOx1 nCoV-19) vaccination.
    Soboleva K; Shankar NK; Yadavalli M; Ferreira C; Foskett N; Putsepp K; Ferstenberg LB; Nord M; da Silva HG; Bhuyan P
    Lancet Glob Health; 2022 Jan; 10(1):e33-e34. PubMed ID: 34919849
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    Hippisley-Cox J; Patone M; Mei XW; Saatci D; Dixon S; Khunti K; Zaccardi F; Watkinson P; Shankar-Hari M; Doidge J; Harrison DA; Griffin SJ; Sheikh A; Coupland CAC
    BMJ; 2021 Aug; 374():n1931. PubMed ID: 34446426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Padniewski JJ; Jacobson-Dunlop E; Albadri S; Hylwa S
    Int J Dermatol; 2022 Aug; 61(8):923-929. PubMed ID: 35398905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinopharm COVID-19 vaccine-induced Stevens-Johnson syndrome.
    Boualila L; Mrini B; Tagmouti A; El Moubarik N; Benchekroun Belabbes M; Boutimzine N; Cherkaoui LO
    J Fr Ophtalmol; 2022 Apr; 45(4):e179-e182. PubMed ID: 35033375
    [No Abstract]   [Full Text] [Related]  

  • 13. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
    Jarius S; Bieber N; Haas J; Wildemann B
    J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal.
    Sah R; Shrestha S; Mehta R; Sah SK; Rabaan AA; Dhama K; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 40():101989. PubMed ID: 33578045
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Ramasamy MN; Minassian AM; Ewer KJ; Flaxman AL; Folegatti PM; Owens DR; Voysey M; Aley PK; Angus B; Babbage G; Belij-Rammerstorfer S; Berry L; Bibi S; Bittaye M; Cathie K; Chappell H; Charlton S; Cicconi P; Clutterbuck EA; Colin-Jones R; Dold C; Emary KRW; Fedosyuk S; Fuskova M; Gbesemete D; Green C; Hallis B; Hou MM; Jenkin D; Joe CCD; Kelly EJ; Kerridge S; Lawrie AM; Lelliott A; Lwin MN; Makinson R; Marchevsky NG; Mujadidi Y; Munro APS; Pacurar M; Plested E; Rand J; Rawlinson T; Rhead S; Robinson H; Ritchie AJ; Ross-Russell AL; Saich S; Singh N; Smith CC; Snape MD; Song R; Tarrant R; Themistocleous Y; Thomas KM; Villafana TL; Warren SC; Watson MEE; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Faust SN; Pollard AJ;
    Lancet; 2021 Dec; 396(10267):1979-1993. PubMed ID: 33220855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
    Marchevsky NG; Li G; Aley P; Costa Clemens SA; Barrett JR; Belij-Rammerstorfer S; Bibi S; Clutterbuck E; Dold C; Felle S; Flaxman A; Folegatti P; Jenkin D; Gilbert S; Kelly S; Lambe T; Plested E; Ramasamy M; Singh N; Smith H; Taylor S; Weckx L; Pollard AJ; Voysey M;
    EBioMedicine; 2022 Jul; 81():104128. PubMed ID: 35779491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).
    Paulsen FO; Schaefers C; Langer F; Frenzel C; Wenzel U; Hengel FE; Bokemeyer C; Seidel C
    Blood; 2021 Sep; 138(11):996-999. PubMed ID: 34297792
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial.
    Madhi SA; Koen AL; Izu A; Fairlie L; Cutland CL; Baillie V; Padayachee SD; Dheda K; Barnabas SL; Bhorat QE; Briner C; Aley PK; Bhikha S; Hermanus T; Horne E; Jose A; Kgagudi P; Lambe T; Masenya M; Masilela M; Mkhize N; Moultrie A; Mukendi CK; Moyo-Gwete T; Nana AJ; Nzimande A; Patel F; Rhead S; Taoushanis C; Thombrayil A; van Eck S; Voysey M; Villafana TL; Vekemans J; Gilbert SC; Pollard AJ; Moore PL; Kwatra G;
    Lancet HIV; 2021 Sep; 8(9):e568-e580. PubMed ID: 34416193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report.
    de Mélo Silva ML; Lopes DP
    Acta Neurol Scand; 2021 Dec; 144(6):717-718. PubMed ID: 34273119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.